June Health Tirzepatide Review: Product Prices & Conflicting Terms

June Health’s “Tirzepatide with (B12 or Glycine)” product page defaults to a one-month purchase at $199 today, with no subscription or renewal. Other one-month strength selections show $249 or $299 today. The shop and the same product’s “Quick Facts” still show from $409, so obtain the final prescription-specific quote before paying.^8,9

Confirm the actual prescription and charge

The longer-plan buttons advertise a first month free, $30 shipping today, then $747 for the three-month plan, $1,350 for six months or $2,388 for twelve months in 30 days. The selected three-month panel says $747 is charged once in 30 days as a single subscription renewal and that cancellation before then avoids that later charge. Do not assume additional recurring cycles, an accepted personal agreement or the same detailed mechanism for every other plan. The page also advertises free shipping; confirm how the $30 promotional shipping charge applies.^8,5

The default variant label combines “5 mg,” “0.5 mg/mL” and a “2 mL vial”; other selections use different strength labels. These descriptions do not establish your actual prescription, concentration or administered dose. Confirm the pharmacy label, supplied quantity, complete charge and any laboratory or extra-service costs with the provider.^8,4

The public terms, dated July 22, 2026, label themselves a general template that should be reviewed before publication. Confirm the final agreement governing your selected plan; these provisions do not establish what you have accepted. The template describes recurring charges only if you enroll in a recurring or subscription plan. Cancellation follows the instructions given at purchase or support contact. The shipping/returns policy says to cancel before the next renewal; obtain the actual renewal date and required cutoff in the selected agreement.^4,5

Consultation review can make a fee nonrefundable

The terms say fees generally become nonrefundable once a consultation is completed or medication is prepared or shipped. The shipping/returns policy more specifically says consultation fees are nonrefundable once a provider completes a clinical review. The product page instead says a card is charged only after prescription approval, that nonapproved patients are not charged, and that dissatisfaction within 30 days qualifies for a first-order refund “no questions.” Obtain the specific agreement reconciling those promises with consultation and medication finality; do not assume either wording supplies every exception.^4,5,8

Orders already reviewed and dispensed generally cannot be canceled, and prescription medication cannot be returned or resold once shipped. If an order arrives damaged or incorrect, or there is a medication-related concern, the policy asks patients to contact support within seven days for provider/pharmacist review. It does not promise every report a cash refund.⁵

When a refund is issued, it returns to the original payment method within five to ten business days. Undeliverable or refused shipments may incur reshipment fees. The stated pharmacy processing time is typically two to five business days after approval, with compounded medication potentially taking longer; a delivery estimate is not a guarantee.⁵

The platform names independent care groups

June Health’s terms identify June Health LLC as the platform and name SamaritanMD and BeyondMD among independent medical groups. They say the treating group depends on your state and clinician authorization, with the actual group and clinician disclosed during the visit. Those names do not establish your assigned practice or current credentials.^4,6

The disclosures say provider groups arrange 503A compounding or dispensing pharmacy fulfillment, that June does not hold a direct pharmacy contract and that it does not partner with 503B outsourcing facilities. These are attributed company disclosures, not proof of the license or facility that will prepare your prescription. Ask for the actual dispenser and prescription label.^4,6

The homepage excludes Massachusetts, Rhode Island and Vermont from its broad provider-availability statement. Confirm the selected treatment in your location. Brand-drug trials do not establish outcomes for this platform or an oral/compounded preparation; SURMOUNT-1 and SURMOUNT-5 provide clinical context.^1,2,7

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, BiltRx, best tirzepatide providers.